Roman Shrestha1, Michael M Copenhaver2. 1. Department of Allied Health Sciences, University of Connecticut, Storrs, CT, USA; Institute for Collaboration on Health, Intervention, and Policy, University of Connecticut, Storrs, CT, USA. Electronic address: roman.shrestha@uconn.edu. 2. Department of Allied Health Sciences, University of Connecticut, Storrs, CT, USA; Institute for Collaboration on Health, Intervention, and Policy, University of Connecticut, Storrs, CT, USA.
Abstract
INTRODUCTION: Methadone maintenance therapy (MMT) is associated with improved virologic outcomes, yet no studies have explored factors associated with viral suppression in HIV-infected patients on MMT. Given the critical role of sustained viral suppression in maximizing benefits of antiretroviral therapy (ART), we sought to assess factors associated with viral suppression in patients stabilized on MMT. METHODS: A sample of 133 HIV-infected, methadone-maintained patients who reported HIV-risk behaviors were assessed using an audio-computer assisted self-interview (ACASI). Multivariable logistic regression was used to identify significant correlates of viral suppression. RESULTS: Among all participants, self-reported HIV risk behaviors were highly prevalent and over 80% had achieved viral suppression. Independent correlates of viral suppression were: having optimal adherence to ART (aOR = 4.883, p = .009), high CD4 count (aOR = 2.483, p = .045), and ongoing injection drug use (aOR = 0.081, p = .036). Furthermore, results revealed a significant interaction effect that involved optimal ART adherence and injection of drug use on viral suppression (aOR = 2.953, p = .029). CONCLUSION: Overall, our findings highlight unaddressed HIV-related treatment challenges faced by certain group of methadone-maintained patients. These findings have significant implications for the HIV treatment as prevention efforts and, thus, indicate the need for comprehensive efforts to promote viral suppression in this risk population.
INTRODUCTION:Methadone maintenance therapy (MMT) is associated with improved virologic outcomes, yet no studies have explored factors associated with viral suppression in HIV-infectedpatients on MMT. Given the critical role of sustained viral suppression in maximizing benefits of antiretroviral therapy (ART), we sought to assess factors associated with viral suppression in patients stabilized on MMT. METHODS: A sample of 133 HIV-infected, methadone-maintained patients who reported HIV-risk behaviors were assessed using an audio-computer assisted self-interview (ACASI). Multivariable logistic regression was used to identify significant correlates of viral suppression. RESULTS: Among all participants, self-reported HIV risk behaviors were highly prevalent and over 80% had achieved viral suppression. Independent correlates of viral suppression were: having optimal adherence to ART (aOR = 4.883, p = .009), high CD4 count (aOR = 2.483, p = .045), and ongoing injection drug use (aOR = 0.081, p = .036). Furthermore, results revealed a significant interaction effect that involved optimal ART adherence and injection of drug use on viral suppression (aOR = 2.953, p = .029). CONCLUSION: Overall, our findings highlight unaddressed HIV-related treatment challenges faced by certain group of methadone-maintained patients. These findings have significant implications for the HIV treatment as prevention efforts and, thus, indicate the need for comprehensive efforts to promote viral suppression in this risk population.
Authors: D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh Journal: Ann Intern Med Date: 2000-07-04 Impact factor: 25.391
Authors: Arthur E Blank; Jason Fletcher; Niko Verdecias; Iliana Garcia; Oni Blackstock; Chinazo Cunningham Journal: AIDS Patient Care STDS Date: 2014-12-02 Impact factor: 5.078
Authors: Yuehan Zhang; Tracey E Wilson; Adebola Adedimeji; Daniel Merenstein; Joel Milam; Jennifer Cohen; Mardge Cohen; Elizabeth T Golub Journal: AIDS Behav Date: 2018-03
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Leslie Cottle; Xinyi C Zhang; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Sharlaa Faesen; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David D Celentano; Max Essex; Sarah E Hudelson; Andrew D Redd; Thomas R Fleming Journal: N Engl J Med Date: 2016-07-18 Impact factor: 91.245
Authors: Rashida A Ferrand; Datonye Briggs; Jane Ferguson; Martina Penazzato; Alice Armstrong; Peter MacPherson; David A Ross; Katharina Kranzer Journal: Trop Med Int Health Date: 2016-01-10 Impact factor: 2.622
Authors: M X Nguyen; H L Reyes; B W Pence; K E Muessig; H E Hutton; C A Latkin; D Dowdy; G Chander; K E Lancaster; C Frangakis; T Sripaipan; H V Tran; V F Go Journal: AIDS Behav Date: 2021-11-22
Authors: Amon Exavery; John Charles; Erica Kuhlik; Asheri Barankena; Ramadhani Abdul; Godfrey M Mubyazi; Christina Kyaruzi; Levina Kikoyo; Elizabeth Jere; Marianna Balampama Journal: Front Public Health Date: 2022-02-21
Authors: Malia Duffy; Anna Ghosh; Ana Geltman; Gabriel Kieto Mahaniah; Molly Higgins-Biddle; Michele Clark Journal: Med Care Res Rev Date: 2021-10-11 Impact factor: 2.971
Authors: Jonathan Feelemyer; Kamyar Arasteh; Duong T Huong; Khuat T H Oanh; Pham M Khue; Hoang T Giang; Nham T T Thanh; Jean Pierre Moles; Vu H Vinh; Roselyne Vallo; Catherine Quillet; Delphine Rapoud; Sao M Le; Laurent Michel; Didier Laureillard; Nicolas Nagot; Don C Des Jarlais Journal: AIDS Date: 2020-11-01 Impact factor: 4.632